This is a preview of subscription content, log in via an institution to check access.
Reference
Initiative for Medicines, Access & Knowledge (I-MAK). Gilead attempt to secure patent on hepatitis C drug opposed in India. Media Release : 22 Nov 2013. Available from: URL: http://www.i-mak.org
Additional information
* Initiative for Medicines, Access & Knowledge
Rights and permissions
About this article
Cite this article
Gilead's sofosbuvir patent application opposed in India. PharmacoEcon Outcomes News 693, 10 (2013). https://doi.org/10.1007/s40274-013-0945-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0945-x